List of Tables
    Table 1. Human Coagulation Factor Ⅷ CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Coagulation Factor Ⅷ Market Trends
    Table 3. Human Coagulation Factor Ⅷ Market Drivers
    Table 4. Human Coagulation Factor Ⅷ Market Challenges
    Table 5. Human Coagulation Factor Ⅷ Market Restraints
    Table 6. Global Human Coagulation Factor Ⅷ Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Coagulation Factor Ⅷ Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Coagulation Factor Ⅷ Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Coagulation Factor Ⅷ Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Coagulation Factor Ⅷ Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Coagulation Factor Ⅷ Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Coagulation Factor Ⅷ Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Coagulation Factor Ⅷ Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Human Coagulation Factor Ⅷ Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Coagulation Factor Ⅷ Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Human Coagulation Factor Ⅷ Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Coagulation Factor Ⅷ by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor Ⅷ as of 2021)
    Table 18. Top Players of Human Coagulation Factor Ⅷ in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Coagulation Factor Ⅷ Product Type
    Table 20. Date of International Manufacturers Enter into Human Coagulation Factor Ⅷ Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Coagulation Factor Ⅷ Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Coagulation Factor Ⅷ Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Coagulation Factor Ⅷ Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Coagulation Factor Ⅷ Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Human Coagulation Factor Ⅷ Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Coagulation Factor Ⅷ Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Coagulation Factor Ⅷ Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Human Coagulation Factor Ⅷ Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Human Coagulation Factor Ⅷ Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Coagulation Factor Ⅷ Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Coagulation Factor Ⅷ Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Human Coagulation Factor Ⅷ Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Coagulation Factor Ⅷ Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Human Coagulation Factor Ⅷ Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Coagulation Factor Ⅷ Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Human Coagulation Factor Ⅷ Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Coagulation Factor Ⅷ Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Human Coagulation Factor Ⅷ Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Coagulation Factor Ⅷ Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Human Coagulation Factor Ⅷ Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Bayer Corporation Information
    Table 43. Bayer Description and Business Overview
    Table 44. Bayer Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Bayer Human Coagulation Factor Ⅷ Product
    Table 46. Bayer Recent Development
    Table 47. CSL Behring Corporation Information
    Table 48. CSL Behring Description and Business Overview
    Table 49. CSL Behring Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. CSL Behring Product
    Table 51. CSL Behring Recent Development
    Table 52. Baxter Corporation Information
    Table 53. Baxter Description and Business Overview
    Table 54. Baxter Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Baxter Product
    Table 56. Baxter Recent Development
    Table 57. Grifols Corporation Information
    Table 58. Grifols Description and Business Overview
    Table 59. Grifols Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Grifols Product
    Table 61. Grifols Recent Development
    Table 62. Octapharma Corporation Information
    Table 63. Octapharma Description and Business Overview
    Table 64. Octapharma Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Octapharma Product
    Table 66. Octapharma Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Taibang Bio Corporation Information
    Table 73. Taibang Bio Description and Business Overview
    Table 74. Taibang Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Taibang Bio Product
    Table 76. Taibang Bio Recent Development
    Table 77. Shanghai Laishi Corporation Information
    Table 78. Shanghai Laishi Description and Business Overview
    Table 79. Shanghai Laishi Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Shanghai Laishi Product
    Table 81. Shanghai Laishi Recent Development
    Table 82. Hualan Bio Corporation Information
    Table 83. Hualan Bio Description and Business Overview
    Table 84. Hualan Bio Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Hualan Bio Product
    Table 86. Hualan Bio Recent Development
    Table 87. Guangdong Shuanglin Corporation Information
    Table 88. Guangdong Shuanglin Description and Business Overview
    Table 89. Guangdong Shuanglin Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Guangdong Shuanglin Product
    Table 91. Guangdong Shuanglin Recent Development
    Table 92. GreenCross Corporation Information
    Table 93. GreenCross Description and Business Overview
    Table 94. GreenCross Human Coagulation Factor Ⅷ Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. GreenCross Product
    Table 96. GreenCross Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Human Coagulation Factor Ⅷ Customers List
    Table 100. Human Coagulation Factor Ⅷ Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Coagulation Factor Ⅷ Product Picture
    Figure 2. Global Human Coagulation Factor Ⅷ Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Coagulation Factor Ⅷ Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Coagulation Factor Ⅷ Sales 2017-2028 (K Units)
    Figure 5. United States Human Coagulation Factor Ⅷ Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Coagulation Factor Ⅷ Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Coagulation Factor Ⅷ Sales 2017-2028 (K Units)
    Figure 8. United States Human Coagulation Factor Ⅷ Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Coagulation Factor Ⅷ Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Human Coagulation Factor Ⅷ Report Years Considered
    Figure 11. Product Picture of Recombinant Factor VIII
    Figure 12. Product Picture of Human Factor VIII
    Figure 13. Global Human Coagulation Factor Ⅷ Market Share by Type in 2022 & 2028
    Figure 14. Global Human Coagulation Factor Ⅷ Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Human Coagulation Factor Ⅷ Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Human Coagulation Factor Ⅷ Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Human Coagulation Factor Ⅷ Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Human Coagulation Factor Ⅷ Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Human Coagulation Factor Ⅷ Market Share by Type in 2022 & 2028
    Figure 20. United States Human Coagulation Factor Ⅷ Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Human Coagulation Factor Ⅷ Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Human Coagulation Factor Ⅷ Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Human Coagulation Factor Ⅷ Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Human Coagulation Factor Ⅷ Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hemophilia A
    Figure 26. Product Picture of Relvent Bleeding Diseases
    Figure 27. Global Human Coagulation Factor Ⅷ Market Share by Application in 2022 & 2028
    Figure 28. Global Human Coagulation Factor Ⅷ Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Human Coagulation Factor Ⅷ Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Human Coagulation Factor Ⅷ Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Human Coagulation Factor Ⅷ Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Human Coagulation Factor Ⅷ Price by Application (2017-2028) & (US$/Unit)
    Figure 33. United States Human Coagulation Factor Ⅷ Market Share by Application in 2022 & 2028
    Figure 34. United States Human Coagulation Factor Ⅷ Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Human Coagulation Factor Ⅷ Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Human Coagulation Factor Ⅷ Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Human Coagulation Factor Ⅷ Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Human Coagulation Factor Ⅷ Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Human Coagulation Factor Ⅷ Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Human Coagulation Factor Ⅷ Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. U.S. Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Human Coagulation Factor Ⅷ Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Human Coagulation Factor Ⅷ Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Human Coagulation Factor Ⅷ Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Human Coagulation Factor Ⅷ Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Taiwan Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Philippines Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Latin America Human Coagulation Factor Ⅷ Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 63. Latin America Human Coagulation Factor Ⅷ Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 64. Mexico Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Brazil Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Argentina Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Human Coagulation Factor Ⅷ Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 68. Middle East & Africa Human Coagulation Factor Ⅷ Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Human Coagulation Factor Ⅷ Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Human Coagulation Factor Ⅷ Value Chain
    Figure 73. Human Coagulation Factor Ⅷ Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed